+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Beta-3 Receptors Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-3 Receptors Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HIF-1 Alpha Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

HIF-1 Alpha Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Environmental Trends in Healthcare - Thematic Intelligence - Product Thumbnail Image

Environmental Trends in Healthcare - Thematic Intelligence

  • Report
  • January 2023
  • 57 Pages
  • Global
From
Benign Prostatic Hyperplasia (BPH) Devices Market 2024-2028 - Product Thumbnail Image

Benign Prostatic Hyperplasia (BPH) Devices Market 2024-2028

  • Report
  • October 2024
  • 139 Pages
  • Global
From
Markets at a Glance: Pharmaceuticals - Product Thumbnail Image

Markets at a Glance: Pharmaceuticals

  • Report
  • May 2019
  • 115 Pages
  • Global
From
Nordic Pharmaceutical Manufacturers - Industry Report - Product Thumbnail Image

Nordic Pharmaceutical Manufacturers - Industry Report

  • Report
  • May 2025
  • 150 Pages
  • Sweden, Norway, Iceland, ... Sweden, Norway, Iceland, Finland, Denmark
From
Anti-anemic Drug Market - Forecasts from 2020 to 2025 - Product Thumbnail Image

Anti-anemic Drug Market - Forecasts from 2020 to 2025

  • Report
  • April 2020
  • 125 Pages
  • Global
From
From
From
Loading Indicator